BCAX
Bicara Therapeutics Inc.
19.20$
-2.9%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Cash Flow
Bicara Therapeutics Inc. (BCAX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Operating Cash Flow" came in at -44 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -11 | -8.0 | -15 | -13 | -17 | -30 | -28 | -26 | -29 | -24 | -38 | -44 | -135 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.3 | 0.0 | 0.0 | 0.4 | |
| 0.5 | 0.8 | 1.1 | 1.0 | 2.0 | 3.2 | 3.5 | 3.5 | 3.6 | 4.4 | 5.9 | 8.2 | 22 | |
| -1.6 | 2.9 | -3.3 | 3.0 | -1.9 | -12 | 5.1 | -1.9 | 3.2 | 8.4 | 12 | 14 | 38 | |
| 0.2 | 0.4 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.2 | 0.1 | 0.1 | 0.4 | |
| -0.2 | -0.4 | 0.1 | 0.0 | 0.0 | 0.0 | – | – | -236 | -82 | 101 | -185 | -403 | |
| 40 | 195 | 0.1 | 0.7 | 334 | -1.0 | 0.5 | 0.1 | 0.4 | 31 | 163 | 2.3 | 197 | |
| 29 | 186 | -14 | -12 | 317 | -31 | -28 | -25 | -265 | -75 | 227 | -227 | -340 | |
| -11 | -8.5 | -15 | -13 | -17 | -30 | -28 | -26 | -29 | -24 | -38 | -44 | -135 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.